<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Drug Discovery on DBBS Tech Blog</title>
    <link>https://blog.dbbstech.com/tags/drug-discovery/</link>
    <description>Recent content in Drug Discovery on DBBS Tech Blog</description>
    <generator>Hugo -- 0.147.0</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 17 Apr 2026 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://blog.dbbstech.com/tags/drug-discovery/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>GPT-Rosalind: OpenAI&#39;s Bold Bet That AI Can Crack Drug Discovery</title>
      <link>https://blog.dbbstech.com/posts/2026-04-17-openai-gpt-rosalind-drug-discovery/</link>
      <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
      <guid>https://blog.dbbstech.com/posts/2026-04-17-openai-gpt-rosalind-drug-discovery/</guid>
      <description>OpenAI launches GPT-Rosalind, a biology-tuned AI model for drug discovery. With Amgen, Moderna, and Novo Nordisk on board, this changes the game.</description>
    </item>
  </channel>
</rss>
